Trials / Completed
CompletedNCT03062163
Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers
Detailed description
66 participants with overweight received a resveratrol and lipoic acid transdermal patch treatment. The treatment areas have been treated including left and right arms. Subjects were evaluated using standardized measurements of body weight and circumference of arms at baseline and 2 weeks follow-up visits. Evaluation of physician were also measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Resveratrol lipoic Acid | Transdermal patch loaded with resveratrol and lipoic acid |
| OTHER | Placebo | Transdermal patch loaded with normal saline |
Timeline
- Start date
- 2017-01-23
- Primary completion
- 2017-02-06
- Completion
- 2017-02-06
- First posted
- 2017-02-23
- Last updated
- 2017-02-23
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03062163. Inclusion in this directory is not an endorsement.